Royce & Associates’s Celestica CLS Stock Holding History

Royce & Associates’s Portfolio CLS Stock Details CLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,982,635	Closed	-$16.8M	–	1163
2019 Q1	$16.8M	Buy	1,982,635 +190,400	+11%	+$1.7M	0.14%	189
2018 Q4	$15.7M	Sell	1,792,235 -908,251	-34%	-$9.1M	0.14%	187
2018 Q3	$29.2M	Sell	2,700,486 -152,250	-5%	-$1.83M	0.2%	120
2018 Q2	$33.9M	Sell	2,852,736 -555,400	-16%	-$6.37M	0.23%	108
2018 Q1	$35.3M	Sell	3,408,136 -553,653	-14%	-$5.96M	0.25%	98
2017 Q4	$41.5M	Buy	3,961,789 +854,186	+27%	+$9.45M	0.28%	77
2017 Q3	$38.5M	Buy	3,107,603 +293,295	+10%	+$3.61M	0.26%	92
2017 Q2	$38.2M	Buy	2,814,308 +1,134,594	+68%	+$15.9M	0.25%	96
2017 Q1	$24.4M	Buy	+1,679,714	New	+$22.4M	0.16%	177

Other funds holding CLS

LBA

Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return

GCC

Guardian Capital (Canada) Toronto, Ontario, Canada $4.11B AUM 27.59% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

DSC

Donald Smith & Co New York $5.65B AUM 47.79% 1-Year Est. Return

AIMCA

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Royce & Associates's CLS Position: Q2 2019 in Review

Royce & Associates sold out of Celestica (CLS) in Q2 2019, closing a stake of 1,982,635 shares — an estimated $16.8M sold.

Royce & Associates first reported a position in CLS in Q1 2017 and held it in 9 quarters. The position peaked at $41.5M in Q4 2017. 101 funds tracked by Wall St. Rank hold CLS as of Q2 2019.

Royce & Associates reported no remaining Celestica position as of Q2 2019 after selling out during the quarter.
Royce & Associates sold 1,982,635 Celestica shares in Q2 2019, an estimated $16.8M.
Royce & Associates first reported a position in Celestica in Q1 2017 and held it in 9 quarters.
Royce & Associates's Celestica position peaked at $41.5M in Q4 2017.
101 funds tracked by Wall St. Rank held Celestica as of Q2 2019.

Based on Royce & Associates's 13F filing for Q2 2019, filed 12 Aug 2019.